Disclosure(s): No financial relationships to disclose
Disclosure(s):
Anthony DeWilde, OD: No financial relationships to disclose
Anti-VEGF medication has caused a paradigm shift in the maintenance of retinal vein occlusions, diabetic retinopathy, and wet age-related macular degeneration. This course highlights the diagnosis, treatment, and referral of these conditions now that Anti-VEGF is the standard treatment.
Learning Objectives:
Upon conclusion of this activity, attendees will be able to:
